Keine Produkte auf Ihrer Vergleichsliste.
Ihr Warenkorb ist leer.
Alle Spezies anzeigen
Weitere Synonyme anzeigen
Wählen Sie die Spezies und Applikation aus
anti-Human EPO Antikörper:
anti-Rat (Rattus) EPO Antikörper:
anti-Mouse (Murine) EPO Antikörper:
Sie gelangen zu unserer vorgefilterten Suche.
Human Polyclonal EPO Primary Antibody für IF (p), IHC (p) - ABIN679718
DeNiro, Al-Mohanna: Nuclear factor kappa-B signaling is integral to ocular neovascularization in ischemia-independent microenvironment. in PLoS ONE 2014
Show all 4 Pubmed References
Human Polyclonal EPO Primary Antibody für ELISA, WB - ABIN153425
Ryou, Choudhury, Li, Winters, Yuan, Liu, Yang: Methylene blue-induced neuronal protective mechanism against hypoxia-reoxygenation stress. in Neuroscience 2015
Show all 2 Pubmed References
Human Polyclonal EPO Primary Antibody für IHC, WB - ABIN6679842
Deng, Qin, Cai, Zhong, Zhang, Yu: Rutaecarpine Suppresses Proliferation and Promotes Apoptosis of Human Pulmonary Artery Smooth Muscle Cells in Hypoxia Possibly Through HIF-1α-Dependent Pathways. in Journal of cardiovascular pharmacology 2018
Human Monoclonal EPO Primary Antibody für ELISA, WB - ABIN515362
Wang, Dou, Lü, Liu: Immuno-magnetic beads-based extraction-capillary zone electrophoresis-deep UV laser-induced fluorescence analysis of erythropoietin. in Journal of chromatography. A 2012
Human Monoclonal EPO Primary Antibody für ICC, ELISA - ABIN969109
Hirschler-Laszkiewicz, Tong, Conrad, Zhang, Flint, Barber, Barber, Cheung, Miller: TRPC3 activation by erythropoietin is modulated by TRPC6. in The Journal of biological chemistry 2009
Human Monoclonal EPO Primary Antibody für WB - ABIN2473499
Gladun: [Theoretical problems of legal regulations of the reorganization of public health in the USSR]. in Sovetskoe zdravookhranenie / Ministerstvo zdravookhranenii?a SSSR 1991
Show all 4 Pubmed References
Data show that erythropoietin (EPO) mRNA was upregulated in the lung, from the metamorphic climax (stage 60) onward.
Chronic kidney disease did not significantly alter IL-6 genotypes, but IL-6 gene polymorphism had a significant effect on serum erythropoietin levels and a nonsignificant effect on Hb levels.
Cross-over study in healthy subjects reveal that reduced arterial oxygen content (CaO2) induces similar increases in circulating erythropoietin (EPO) concentration irrespective of arterial oxygen tension (PaO2) manipulation, demonstrating that CaO2 is the critical variable regulating EPO production.
role of CPC1 in the negative regulation of NF-kappaB activation through positive regulation of the HIF-1alpha/EPO axis.
these data suggest that increased EPO/EPO-R expression may play an important role in cervical carcinogenesis. EPO overexpression may promote Vasculogenic mimicry (VM) formation in cervical squamous cell carcinoma.
Study conclude that physiologically slow-rising serum erythropoietin levels in breast cancer patients in response to tumor-related or chemotherapy-induced anemia, as opposed to large doses of recombinant erythropoietin, do not increase the pool of breast cancer-initiating cells.
demonstrated that different mechanisms are involved in the erythropoietin hypersensitivity phenotype, according to the type of EPOR mutation
FAM210B is an erythropoietin target and regulates erythroid heme synthesis by controlling mitochondrial iron import and ferrochelatase activity
To date, 28 variants of the EPOR and seven variants of the EPO gene have been associated with erythrocytosis or upper hematocrit. Sequence variants were also found to be present within regulatory regions.
Study provides evidence of increased placental EPO expression in monochorionic twin fetuses with selective intrauterine growth restriction and abnormal umbilical artery Doppler.
In this case-control study, the erythropoietin (EPO) promoter variant s1617640, linked to high intravitreal EPO concentrations and increased risk of diabetic retinopathy, was not associated with severe retinopathy of prematurity. This finding was observed both in infants with and without recombinant EPO administration.
These data suggest that reduced kidney erythropoietin synthesis could be caused by the accumulation of abnormal extracellular matrix proteins.
When anemia or hypoxia occurs, transcriptional factor, hypoxia-inducible factor (HIF), binds to EPO 5' hypoxic response element and EPO gene transcription increases. In CKD, pericytes transdifferentiate to myofibroblasts, and subsequently the ability of EPO production decreases, leading to renal anemia. Recent advances on epigenetics create a new field to study EPO gene expression at chromatin level.
Integrative view on how erythropoietin signaling controls transcription patterns in erythroid cells.
Increases in plasma erythropoietin and erythropoietin receptor activation are mechanisms implicated in the increase of plasma FGF23 in acute kidney injury.
the implication of alpha-7-nAChR-JAK-2/STAT-3-Nrf-2 signaling cascade in the radiomitigative potential of EPO against ARS
Pro-inflammatory proteins S100A9 and tumor necrosis factor-alpha suppress erythropoietin elaboration in myelodysplastic syndromes
Results suggest an interplay of the production and action of hydrogen sulfide during hypoxia with subsequent erythropoietin production regulated by HIF-1alpha and HIF-2alpha.
EPO levels in the coronary artery disease (CAD) group were higher than those in the non-CAD group. The correlation between red cell distribution width and EPO levels was statistically significant among CAD patients.
CD133(+) cells contributed to the local production of erythropoietin, as observed by detection of circulating human erythropoietin. CD133(+) cells appear therefore an effective source for cell repair, able to restore renal functions, including erythropoietin release, and to limit long term maldifferentiation and fibrosis.
Circulating anti-EPO are detected in a significant proportion of treatment-naive HCV-infected patients and are independently associated with anemia, suggesting a further implication of autoimmunity in the pathophysiology of HCV-related anemia.
VEGF as a new player in Epo induction and perivascular Gli1(+)SMA(+)PDGFRbeta(+) cells as a previously unrecognized EPC reservoir that could be harnessed for augmenting Epo synthesis in circumstances such as chronic kidney disease where production by canonical EPCs is compromised.
Anemia could disturb T cell movement in the spleen, which might further affect T cell immune response, with partial involvement of EPO.
the deficiency of macrophage erythropoietin (EPO) signaling contributed to delayed acute inflammation resolution in diet-induced obese mice.
MEPO promotes neurogenesis and angiogenesis but suppresses gliogenesis in mice with acute ischemic stroke
The intranasal EPOexerted neuroprotection was almost abolished when the specific Nrf2 antagonist ATRA was administered intraperitoneally prior to intranasal EPO treatment.
The neuroprotective effect of brain Epo overexpression prevents oxidative damage in the brain and cardiorespiratory disorders induced by chronic intermittent hypoxia.
Compared to wild type (WT) animals, Epo-TAg(h) female mice exhibited higher ventilation in hypoxia. However, when data were separated into luteal and follicular phases of the estrous cycle, basal ventilation and hypoxic ventilation were not different in both mice strains. Experiments with mifepristone (progesterone receptor antagonist) suggest that this effect is independent from the respiratory effects of progesterone.
this study revealed a new mechanism wherein EPO alleviates hepatic steatosis by activating autophagy via SIRT1-dependent deacetylation of LC3.
This study suggests that moderate elevated brain Epo levels provide clinically significant neuroprotection in experimental autoimmune encephalomyelitis without modulation of the immune response making a significant contribution.
The functional role of signal cascades involved in the production of erythropoietin by T cells is determined by the stage of the common adaptation syndrome.
A novel biological pathway has been discovered of soluble biglycan inducing HIF-2alpha protein stabilization and Epo production presumably in an oxygen-independent manner, ultimately giving rise to secondary polycythemia.
data identify the PHD2:HIF-2alpha:EPO axis as a so far unknown regulator of osteohematology by controlling bone homeostasis.
these data provide strong evidence for a role for G-CSF in the development of ACI after burn injury through suppression of EPO signaling in bone marrow erythroid cells.
Data indicated the possible involvement of Jak2/STAT3/STAT6 pathway in the augmentation of EPO on M2 polarization. These results improved the understanding of the immunoregulatory capacity of EPO on macrophages, which might optimize the therapeutic modalities of EPO.
The lack of effect of erythropoietin on hepcidin expression in mask mice can not be explained by changes in erythroferrone synthesis, as splenic erythroferrone content increased after erythropoietin administration in both C57BL/6 and mask mice.
EPO expression in myoblasts and myotubes is increased by hypoxia and exercise
these findings define a cis-regulatory enhancer network for Epo signaling during erythropoiesis, and provide the framework for future studies involving the interplay of epigenetics and Epo signaling.
FOXD1 lineage renal interstitial cells consist of distinct subpopulations that differ in their responsiveness to Phd2 inactivation and thus regulation of HIF-2 activity and EPO production under hypoxia or conditions of pharmacologic or genetic PHD inactivation.
EPO might play a role as a survival factor or as a mitogen in developing cartilage tissue.
Pyruvate-fortified cardioplegia evokes myocardial erythropoietin signaling in swine undergoing cardiopulmonary bypass.
A single intramuscular injection of recombinant adeno-associated virus carrying mutant Epo (R76E) preserves retinal ganglion cells and visual function in glaucomatous mice.
The zebrafish epo cDNA was cloned and the expression of zepo mRNA was mainly in the heart and liver.
characterization of zebrafish epo and epor demonstrates the conservation of an ancient program that ensures proper red blood cell numbers during normal homeostasis and under hypoxic conditions
This gene is a member of the EPO/TPO family and encodes a secreted, glycosylated cytokine composed of four alpha helical bundles. The protein is found in the plasma and regulates red cell production by promoting erythroid differentiation and initiating hemoglobin synthesis. This protein also has neuroprotective activity against a variety of potential brain injuries and antiapoptotic functions in several tissue types.